4/25
04:08 pm
advm
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting [Yahoo! Finance]
Low
Report
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting [Yahoo! Finance]
4/25
04:05 pm
advm
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Low
Report
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
4/23
11:08 am
advm
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
Medium
Report
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year? [Yahoo! Finance]
4/4
05:39 pm
advm
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight [Yahoo! Finance]
Medium
Report
Gene Therapies in Ophthalmology Market to Register Immense Growth at a CAGR of 57.8% by 2034 | DelveInsight [Yahoo! Finance]
4/4
11:39 am
advm
Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year? [Yahoo! Finance]
Medium
Report
Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year? [Yahoo! Finance]
3/27
11:20 am
advm
Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM) [Yahoo! Finance]
Low
Report
Down -29.25% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM) [Yahoo! Finance]
3/22
02:04 am
advm
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/19
02:24 pm
advm
US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies [Yahoo! Finance]
Low
Report
US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies [Yahoo! Finance]
11/9/2023
04:05 pm
advm
adverum biotechnologies, inc.
MISS
Report
2.9%
adverum biotechnologies, inc.
8/10/2023
04:05 pm
advm
adverum biotechnologies, inc.
BEAT
Report
3.3%
adverum biotechnologies, inc.
5/11/2023
04:05 pm
advm
adverum biotechnologies, inc.
BEAT
Report
-3.6%
adverum biotechnologies, inc.
4/1
06:04 am
advm
Form EFFECT Adverum Biotechnologies,
Low
Report
Form EFFECT Adverum Biotechnologies,
3/27
06:06 am
advm
Form EFFECT Adverum Biotechnologies,
Low
Report
Form EFFECT Adverum Biotechnologies,
3/21
05:25 pm
advm
Form S-3 Adverum Biotechnologies,
Medium
Report
Form S-3 Adverum Biotechnologies,
3/18
04:58 pm
advm
Form S-8 Adverum Biotechnologies,
Medium
Report
Form S-8 Adverum Biotechnologies,
3/18
04:10 pm
advm
Form 10-K Adverum Biotechnologies, For: Dec 31
Low
Report
Form 10-K Adverum Biotechnologies, For: Dec 31
3/18
04:09 pm
advm
Form 8-K Adverum Biotechnologies, For: Mar 18
Medium
Report
Form 8-K Adverum Biotechnologies, For: Mar 18
3/12
07:07 pm
advm
Form 4 Adverum Biotechnologies, For: Oct 03 Filed by: Seyedkazemi Setareh
Low
Report
Form 4 Adverum Biotechnologies, For: Oct 03 Filed by: Seyedkazemi Setareh
3/12
07:06 pm
advm
Form 4 Adverum Biotechnologies, For: Oct 03 Filed by: Soparkar Peter
Low
Report
Form 4 Adverum Biotechnologies, For: Oct 03 Filed by: Soparkar Peter
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register